Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig

Guinea pigs were fed 15% (w/W) fat, high in lauric and myristic acids, a diet known to produce hypercholesterolemia in these animals. The diet was given alone or in combination with four doses of atorvastatin equivalent to 1, 3, 10, and 20 mg/kg per day. Atorvastatin reduced plasma LDL cholesterol c...

Full description

Bibliographic Details
Main Authors: K Conde, M Vergara-Jimenez, B R Krause, R S Newton, M L Fernandez
Format: Article
Language:English
Published: Elsevier 1996-11-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520374861
_version_ 1818385214474289152
author K Conde
M Vergara-Jimenez
B R Krause
R S Newton
M L Fernandez
author_facet K Conde
M Vergara-Jimenez
B R Krause
R S Newton
M L Fernandez
author_sort K Conde
collection DOAJ
description Guinea pigs were fed 15% (w/W) fat, high in lauric and myristic acids, a diet known to produce hypercholesterolemia in these animals. The diet was given alone or in combination with four doses of atorvastatin equivalent to 1, 3, 10, and 20 mg/kg per day. Atorvastatin reduced plasma LDL cholesterol concentrations by 46, 50, 53, and 70%, respectively (P < 0.001). Plasma apoB concentrations were reduced by atorvastatin (P < 0.001) and compositional changes occurred in VLDL and LDL with reductions of the relative proportion of cholesteryl ester and increases in triacylglycerol. A reduction in hepatic cholesteryl ester (66%) was observed only with the highest atorvastatin dose (20 mg/kg per day) while microsomal cholesterol was reduced by 30% with 3-20 mg/kg per day. Hepatic ACAT activity was down-regulated and apoB/E receptor number was increased by atorvastatin. In contrast, HMG-CoA reductase activity and cholesterol 7 alpha-hydroxylase were not affected by the drug. VLDL apoB secretion rates were decreased by atorvastatin treatment 59 and 76% with 3 and 20 mg/kg per day, respectively. Nascent VLDL particles were larger after drug treatment, showing an increased number in triacylglycerol molecules. These results support the hypothesis that the plasma LDL lowering induced by atorvastatin is due to a decreased secretion of apoB in combination with an increase of hepatic apoB/E receptors.
first_indexed 2024-12-14T03:34:36Z
format Article
id doaj.art-efee5b67c61547419ca29a5ea8ee3e33
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-14T03:34:36Z
publishDate 1996-11-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-efee5b67c61547419ca29a5ea8ee3e332022-12-21T23:18:39ZengElsevierJournal of Lipid Research0022-22751996-11-01371123722382Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pigK Conde0M Vergara-Jimenez1B R Krause2R S Newton3M L Fernandez4Department of Nutritional Sciences, University of Arizona, Tucson 85721, USA.Department of Nutritional Sciences, University of Arizona, Tucson 85721, USA.Department of Nutritional Sciences, University of Arizona, Tucson 85721, USA.Department of Nutritional Sciences, University of Arizona, Tucson 85721, USA.Department of Nutritional Sciences, University of Arizona, Tucson 85721, USA.Guinea pigs were fed 15% (w/W) fat, high in lauric and myristic acids, a diet known to produce hypercholesterolemia in these animals. The diet was given alone or in combination with four doses of atorvastatin equivalent to 1, 3, 10, and 20 mg/kg per day. Atorvastatin reduced plasma LDL cholesterol concentrations by 46, 50, 53, and 70%, respectively (P < 0.001). Plasma apoB concentrations were reduced by atorvastatin (P < 0.001) and compositional changes occurred in VLDL and LDL with reductions of the relative proportion of cholesteryl ester and increases in triacylglycerol. A reduction in hepatic cholesteryl ester (66%) was observed only with the highest atorvastatin dose (20 mg/kg per day) while microsomal cholesterol was reduced by 30% with 3-20 mg/kg per day. Hepatic ACAT activity was down-regulated and apoB/E receptor number was increased by atorvastatin. In contrast, HMG-CoA reductase activity and cholesterol 7 alpha-hydroxylase were not affected by the drug. VLDL apoB secretion rates were decreased by atorvastatin treatment 59 and 76% with 3 and 20 mg/kg per day, respectively. Nascent VLDL particles were larger after drug treatment, showing an increased number in triacylglycerol molecules. These results support the hypothesis that the plasma LDL lowering induced by atorvastatin is due to a decreased secretion of apoB in combination with an increase of hepatic apoB/E receptors.http://www.sciencedirect.com/science/article/pii/S0022227520374861
spellingShingle K Conde
M Vergara-Jimenez
B R Krause
R S Newton
M L Fernandez
Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig
Journal of Lipid Research
title Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig
title_full Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig
title_fullStr Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig
title_full_unstemmed Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig
title_short Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig
title_sort hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig
url http://www.sciencedirect.com/science/article/pii/S0022227520374861
work_keys_str_mv AT kconde hypocholesterolemicactionsofatorvastatinareassociatedwithalterationsonhepaticcholesterolmetabolismandlipoproteincompositionintheguineapig
AT mvergarajimenez hypocholesterolemicactionsofatorvastatinareassociatedwithalterationsonhepaticcholesterolmetabolismandlipoproteincompositionintheguineapig
AT brkrause hypocholesterolemicactionsofatorvastatinareassociatedwithalterationsonhepaticcholesterolmetabolismandlipoproteincompositionintheguineapig
AT rsnewton hypocholesterolemicactionsofatorvastatinareassociatedwithalterationsonhepaticcholesterolmetabolismandlipoproteincompositionintheguineapig
AT mlfernandez hypocholesterolemicactionsofatorvastatinareassociatedwithalterationsonhepaticcholesterolmetabolismandlipoproteincompositionintheguineapig